| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Raymond M. Jordt | Chief Business Officer | 2026-01-27 | 4,229 | $6.18 | $26.14kSell |
| M. Scot Roberts | Chief Scientific Officer | 2026-01-27 | 4,748 | $6.18 | $29.34kSell |
| Vipin K. Garg | Director | 2026-01-27 | 17,898 | $6.18 | $110.61kSell |
| M. Scot Roberts | Chief Scientific Officer | 2026-01-25 | 4,373 | $5.50 | $24.05kSell |
| Vipin K. Garg | Director | 2026-01-25 | 17,984 | $5.50 | $98.91kSell |
| Raymond M. Jordt | Chief Business Officer | 2026-01-25 | 3,855 | $5.50 | $21.20kSell |
| Wayne Pisano | Director | 2026-01-08 | 5,000 | $4.08 | $20.41kBuy |
| Catherine A. Sohn | Director | 2026-01-05 | 500 | $4.24 | $2.12kBuy |
| Raymond M. Jordt | Chief Business Officer | 2026-01-01 | 2,475 | $3.61 | $8.93kSell |
| Diane Jorkasky | Director | 2025-12-29 | 527 | $3.80 | $2.00kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Prescott Group Capital Management LLC | 19.03% | 19,837,273 | $111.09M | Insider |
| Novartis Bioventures Ltd | 8.00% | 8,345,145 | $46.73M | Insider |
| Vanguard Group Inc | 6.11% | 6,373,638 | $35.69M | Institution |
| Blackrock Inc | 6.11% | 6,373,259 | $35.69M | Institution |
| Luke Evnin | 6.09% | 6,347,614 | $35.55M | Insider |
| Mpm Bioventures III LLC | 6.09% | 6,347,614 | $35.55M | Insider |
| Healthcare Ventures VII LP | 4.20% | 4,378,057 | $24.52M | Insider |
| State Street Corp | 3.45% | 3,601,255 | $20.17M | Institution |
| Venrock Healthcare Capital Partners III LP | 3.36% | 3,500,000 | $19.60M | Insider |
| James H. Cavanaugh | 3.18% | 3,317,243 | $18.58M | Insider |